Clinical Trial Update: Memory Reconsolidation Blockade for Treating Drug Addiction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating memory reconsolidation blockade as a treatment for substance use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance Use Disorder

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Substance Dependence | Phase 2 | Status: COMPLETED